These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 30362861)

  • 1. Factors Associated with Nonfatal Overdose During a Public Health Emergency.
    Wallace B; Kennedy MC; Kerr T; Pauly B
    Subst Use Misuse; 2019; 54(1):39-45. PubMed ID: 30362861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fentanyl and heroin contained in seized illicit drugs and overdose-related deaths in British Columbia, Canada: An observational analysis.
    Baldwin N; Gray R; Goel A; Wood E; Buxton JA; Rieb LM
    Drug Alcohol Depend; 2018 Apr; 185():322-327. PubMed ID: 29486421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of prescription opioid injection on the risk of non-fatal overdose among people who inject drugs.
    Lake S; Hayashi K; Buxton J; Milloy MJ; Dong H; Wood E; Montaner J; Kerr T
    Drug Alcohol Depend; 2015 Nov; 156():297-303. PubMed ID: 26454837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a fentanyl drug checking service for clients of a supervised injection facility, Vancouver, Canada.
    Karamouzian M; Dohoo C; Forsting S; McNeil R; Kerr T; Lysyshyn M
    Harm Reduct J; 2018 Sep; 15(1):46. PubMed ID: 30200991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fentanyl-contaminated drugs and non-fatal overdose among people who inject drugs in Baltimore, MD.
    Park JN; Weir BW; Allen ST; Chaulk P; Sherman SG
    Harm Reduct J; 2018 Jul; 15(1):34. PubMed ID: 29976195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of take-home opioid antagonist kits during a synthetic opioid epidemic in British Columbia, Canada: a modelling study.
    Irvine MA; Buxton JA; Otterstatter M; Balshaw R; Gustafson R; Tyndall M; Kendall P; Kerr T; Gilbert M; Coombs D
    Lancet Public Health; 2018 May; 3(5):e218-e225. PubMed ID: 29678561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in drug use behaviors coinciding with the emergence of illicit fentanyl among people who use drugs in Vancouver, Canada.
    Brar R; Grant C; DeBeck K; Milloy MJ; Fairbairn N; Wood E; Kerr T; Hayashi K
    Am J Drug Alcohol Abuse; 2020 Sep; 46(5):625-631. PubMed ID: 32689810
    [No Abstract]   [Full Text] [Related]  

  • 8. Motivators of and barriers to drug checking engagement in British Columbia, Canada: Findings from a cross-sectional study.
    Tobias S; Ferguson M; Palis H; Burmeister C; McDougall J; Liu L; Graham B; Ti L; Buxton JA
    Int J Drug Policy; 2024 Jan; 123():104290. PubMed ID: 38101275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knowledge of Fentanyl and Perceived Risk of Overdose Among Persons Who Use Drugs in Vancouver, Canada.
    Moallef S; Nosova E; Milloy MJ; DeBeck K; Fairbairn N; Wood E; Kerr T; Hayashi K
    Public Health Rep; 2019; 134(4):423-431. PubMed ID: 31211644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Willingness to use drug checking within future supervised injection services among people who inject drugs in a mid-sized Canadian city.
    Kennedy MC; Scheim A; Rachlis B; Mitra S; Bardwell G; Rourke S; Kerr T
    Drug Alcohol Depend; 2018 Apr; 185():248-252. PubMed ID: 29475198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Harm reduction measures employed by people using opioids with suspected fentanyl exposure in Boston, Baltimore, and Providence.
    Rouhani S; Park JN; Morales KB; Green TC; Sherman SG
    Harm Reduct J; 2019 Jun; 16(1):39. PubMed ID: 31234942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlates of concurrent use of stimulants and opioids among people who access harm reduction services in British Columbia, Canada: Findings from the 2019 Harm Reduction Client Survey.
    Lukac CD; Steinberg A; Papamihali K; Mehta A; Lock K; Buxton JA
    Int J Drug Policy; 2022 Apr; 102():103602. PubMed ID: 35124412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High prevalence of non-fatal overdose among people who inject drugs in Malaysia: Correlates of overdose and implications for overdose prevention from a cross-sectional study.
    Bazazi AR; Zelenev A; Fu JJ; Yee I; Kamarulzaman A; Altice FL
    Int J Drug Policy; 2015 Jul; 26(7):675-81. PubMed ID: 25532449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterizing fentanyl-related overdoses and implications for overdose response: Findings from a rapid ethnographic study in Vancouver, Canada.
    Mayer S; Boyd J; Collins A; Kennedy MC; Fairbairn N; McNeil R
    Drug Alcohol Depend; 2018 Dec; 193():69-74. PubMed ID: 30343236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations with experience of non-fatal opioid overdose in British Columbia, Canada: a repeated cross sectional survey study.
    Ferguson M; Choisil P; Lamb J; Burmeister C; Newman C; Lock K; Tobias S; Liu L; Buxton JA
    Harm Reduct J; 2023 Dec; 20(1):178. PubMed ID: 38093272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous fentanyl use among people who inject drugs in Australia.
    Geddes L; Iversen J; Memedovic S; Maher L
    Drug Alcohol Rev; 2018 Apr; 37 Suppl 1():S314-S322. PubMed ID: 29405465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substance use patterns associated with recent exposure to fentanyl among people who inject drugs in Vancouver, Canada: A cross-sectional urine toxicology screening study.
    Hayashi K; Milloy MJ; Lysyshyn M; DeBeck K; Nosova E; Wood E; Kerr T
    Drug Alcohol Depend; 2018 Feb; 183():1-6. PubMed ID: 29220642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Awareness of fentanyl exposure and the associated overdose risks among people who inject drugs in a Canadian setting.
    Hayashi K; Wood E; Dong H; Buxton JA; Fairbairn N; DeBeck K; Milloy MJ; Kerr T
    Drug Alcohol Rev; 2021 Sep; 40(6):964-973. PubMed ID: 33604968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heroin and fentanyl overdoses in Kentucky: Epidemiology and surveillance.
    Slavova S; Costich JF; Bunn TL; Luu H; Singleton M; Hargrove SL; Triplett JS; Quesinberry D; Ralston W; Ingram V
    Int J Drug Policy; 2017 Aug; 46():120-129. PubMed ID: 28735777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Awareness, Possession, and Use of Take-Home Naloxone Among Illicit Drug Users, Vancouver, British Columbia, 2014-2015.
    Nolan S; Buxton J; Dobrer S; Dong H; Hayashi K; Milloy MJ; Kerr T; Montaner J; Wood E
    Public Health Rep; 2017; 132(5):563-569. PubMed ID: 28750193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.